Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

GenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer.

10 year partnership with genesis care

Today GenesisCare and the University of Oxford’s Department of Oncology announce the launch of an exclusive 10-year partnership to enhance access to the latest technology in medicine to improve diagnosis, management, and treatment of cancer. A first priority of the partnership will be the installation and use of a Magnetic Resonance Linear Accelerator (MR LinAc) at GenesisCare’s centre in Oxford, along with research into new clinical planning techniques.

The MR LinAc will be used both for research and the treatment of patients in the Oxford area, locating and measuring cancer in real-time and adjusting radiation delivery to changing tumours with unrivalled accuracy. This technology has the potential to drastically change the patient treatment experience and the way in which treatment planning and delivery is conducted.

Read more (Department of Oncology website)